Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

SynGenSys introduces Liver.SET synthetic promoter library for liver-specific gene expression for in vivo gene therapies

SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, today announced the launch of its Liver.SET™ library of liver-specific synthetic promoters.

5 Feb 2026

Optically invisible culture dishes improve embryo imaging in IVF

Selecting the healthiest embryo is one of the most important steps in in‑vitro fertilization (IVF), yet it remains one of the most uncertain.

4 Feb 2026

Clear aligners protect oral microbiome better than fixed braces

Researchers compare the effects of clear aligners and fixed appliances on oral microbiota and oxidative stress in the oral cavity.

4 Feb 2026

Interpower® launches IEC 60320 rewirable Sheet E angled plug connector in black

Adding to its popular line of molded IEC 60320 appliance and interconnection couplers, Interpower announces the launch of its newly manufactured IEC 60320 rewirable Sheet E plug connector in an angled mount configuration initially offered in black.

4 Feb 2026

Shorter working hours boost health, creativity and productivity

Working less can make people healthier - and also more creative and more productive. New research shows that a reduction in working hours can be associated with improved work ability, lower stress levels, and organizational behavioral changes.

3 Feb 2026

Six years after COVID-19: Lessons learned and pandemic preparedness

Six years ago, the Director-General of the World Health Organization sounded the highest global alarm available under international law at the time, declaring the outbreak of a new coronavirus disease (later known as COVID-19) a Public Health Emergency of International Concern (PHEIC).

3 Feb 2026

How the CDC prepares influenza vaccines for pandemics

CDC scientists outline the comprehensive methodology involved in the development of influenza candidate vaccine viruses.

2 Feb 2026

African investment vital for medical research and innovation

Africa’s health future hinges on its ability to finance and commercialise its own medical innovations, rather than rely on increasingly uncertain international funding, African science leaders have warned.

31 Jan 2026

Solvent-free method improves drug solubility using mesoporous silica

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water.

31 Jan 2026

Particle and chemical emissions raise safety concerns in 3D printing

When the manufacture of plastic products moves into ordinary homes, new health problems arise, including emissions of particles and chemicals.

30 Jan 2026

Revolutionizing 3D cell culture with simplified digital microfluidic technology

Most cells in the human body exist in complex three-dimensional environments, yet they are still commonly studied on flat plastic dishes.

30 Jan 2026

Microneedle patches enhance acne treatment with dual drug delivery

Acne vulgaris affects a large proportion of adolescents and young adults and can lead to long-term scarring and psychological distress.

30 Jan 2026

Innovative light control technique improves miniature endoscopic imaging capabilities

Endoscopic optical coherence tomography is widely used to visualize tissue microstructures in real time, but current probes face clear limitations.

30 Jan 2026

Research finds scientists view ELNs as “glorified filing cabinets,” driving frustration, duplication and shadow AI use

Sapio Sciences, the science-aware™ AI lab informatics platform, today announced the results of new research examining scientists’ sentiment around electronic lab notebooks (ELNs) and AI tools in modern laboratory environments.

From Sapio Sciences 27 Jan 2026

JPM highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO platform delivering sustainable high growth

JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

From WuXi Biologics 27 Jan 2026

WuXi Biologics and Hanchorbio enter strategic partnership to advance next-generation bi- and multi-functional fusion protein pipeline

WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio Inc., a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, jointly announced today the signing of a strategic collaboration agreement on the development and manufacturing of multiple next-generation bi-/multi-functional fusion programs from HanchorBio's pipeline.

27 Jan 2026

New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders

This editorial argues that GLP-1 receptor agonists could substantially improve healthspan and reduce premature mortality in people with serious mental illnesses by targeting cardiometabolic risk rather than psychiatric symptoms alone. It highlights emerging evidence, safety considerations, and equity challenges that position GLP-1 RAs as a promising public health strategy for this high-risk population.

25 Jan 2026

New partnership aims to expand global access to sickle cell gene therapy

Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway for patients to access stem cell gene therapies for the treatment of Sickle Cell Disease (SCD).

22 Jan 2026

New ISSCR guidance charts path for pluripotent stem cell therapies

The International Society for Stem Cell Research (ISSCR) today announced the upcoming release of "Charting the Translational Pathway: ISSCR Best Practices for the Development of Pluripotent Stem Cell (PSC)-Derived Therapies," a new paper highlighting some of the most critical aspects of the ISSCR's breakthrough interactive resource designed to transform how PSC-derived therapies are developed, evaluated, and advanced toward clinical and commercial success.

22 Jan 2026

Mcgill researchers find unexpected chemical contaminants in human milk samples

An interdisciplinary team including researchers at McGill University has found a range of unexpected chemical contaminants in human milk samples from Canada and South Africa.

20 Jan 2026